Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Delivery：Within 72h| Full Report Selling Price |
|---|
2800.00 USD |
4200.00 USD |
5600.00 USD |
| Buy NowContact Us |
| Competitor Data Selling Price |
|---|
900.00 USD |
1350.00 USD |
1800.00 USD |
| Buy NowContact Us |
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size will reach 30,899 Million USD in 2026 and is projected to reach 136,942 Million USD by 2033, with a CAGR of 23.70% (2026-2033). Notably, the China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) are two important components in the field of cancer research and treatment. CTCs are rare cancer cells that have detached from a primary tumor and entered the bloodstream, enabling them to potentially spread to other parts of the body and form metastatic tumors. CTCs can be isolated from a patient＇s blood sample and used as a liquid biopsy to provide information about the cancer＇s progression and response to treatment. On the other hand, CSCs are a small subset of cancer cells within a tumor that possess self-renewal and differentiation abilities, similar to stem cells. CSCs are believed to be responsible for tumor initiation, growth, and recurrence, as they have the capacity to regenerate the entire tumor. Both CTCs and CSCs are areas of active research, as their detection, isolation, and characterization hold great potential for improving cancer diagnosis, prognosis, and treatment strategies, aiming at more effective therapies and better patient outcomes.
The major global suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) include Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, ScreenCell, Silicon Biosystems, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs). Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Include:
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Segment Include:
CTC Enrichment
CTC Detection
CTC Analysis
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Application Include:
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry PESTEL Analysis
Chapter 3: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Porter's Five Forces Analysis
Chapter 4: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Player
| Revenue (US$ Million) | 2021 | 2022 | 2023 | 2024 | 2025 |
| Janssen | XX | XX | XX | XX | XX |
| Qiagen | XX | XX | XX | XX | XX |
| Advanced Cell Diagnostics | XX | XX | XX | XX | XX |
| ApoCell | XX | XX | XX | XX | XX |
| Biofluidica | XX | XX | XX | XX | XX |
| Clearbridge Biomedics | XX | XX | XX | XX | XX |
| CytoTrack | XX | XX | XX | XX | XX |
| Celsee | XX | XX | XX | XX | XX |
| Fluxion | XX | XX | XX | XX | XX |
| Gilupi | XX | XX | XX | XX | XX |
| Cynvenio | XX | XX | XX | XX | XX |
| On-chip | XX | XX | XX | XX | XX |
| YZY Bio | XX | XX | XX | XX | XX |
| BioView | XX | XX | XX | XX | XX |
| Fluidigm | XX | XX | XX | XX | XX |
| Ikonisys | XX | XX | XX | XX | XX |
| AdnaGen | XX | XX | XX | XX | XX |
| IVDiagnostics | XX | XX | XX | XX | XX |
| Miltenyi Biotec | XX | XX | XX | XX | XX |
| ScreenCell | XX | XX | XX | XX | XX |
| Silicon Biosystems | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
Related Report
Global Dydrogesterone Drug Competitive Landscape Professional Research Report 2026
Global Dydrogesterone Drug Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Olanzapine Competitive Landscape Professional Research Report 2026
Global Olanzapine Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Oligonucleotide Pool Library Competitive Landscape Professional Research Report 2026
Global Oligonucleotide Pool Library Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Global Oligonucleotide Therapeutics Competitive Landscape Professional Research Report 2026
Global Oligonucleotide Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033
Order Process
Contact
1. Fill in your contact information, and the company will quickly match the specialist to get in touch with you
2. You can also directly call our customer service hotline or add customer service WeChat
Samples
1. One on one business specialist will send the complete version of the sample
2. If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
1. Both parties sign a report purchase contract
2. Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
1. PDF report (sent online 2-3 working days after payment)
2. WORD version report (sent online 2-3 working days after payment)
3. Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
